|
»ç¾÷´ÜÀº 6¿ù 2ÀÏ Çѱ¹Á¦¾àÇùȸ(PRADA), ¼º±Õ°ü´ë DRC¿Í ÇÔ²² Pharmaceutical Technology WorkshopÀ» ´ÙÀ½°ú °°ÀÌ °³ÃÖÇÕ´Ï´Ù.
ÀϽÃ: 2011³â 6¿ù 2ÀÏ(¸ñ) ¿ÀÀü 8:30-¿ÀÈÄ 5:30 Àå¼Ò: ¼º±Õ°ü´ëÇб³ ÀÚ¿¬°úÇÐÄ·ÆÛ½º(¼ö¿ø) ´ë°´ç
À۳⿡ À̾î 2ȸ° °³ÃֵǴ º» ¿öÅ©¼¥Àº Á¦Á¦È °øÁ¤ ¹× Á¦Á¦Àåºñ »ý»êÀ» Àü¹®À¸·ÎÇÏ´Â ´Ù±¹Àû ±â¾÷ÀÎ GEA Pharma Systems°¡ ÈÄ¿øÇϰí ÀÖÀ¸¸ç ¿ÃÇØ¿¡´Â ÀÛ³â°ú ´Þ¸® ÇϷ絿¾È °íÇüÁ¦Á¦ °ü·Ã Á¦Á¦±â¼ú¿¡ °üÇÑ 10°³ÀÇ °Á°¡ °³¼³µË´Ï´Ù.
¿ÃÇØ´Â ÃÑ 6¸íÀÇ ¿Ü±¹ÀÎ ¿¬ÀÚ°¡ ÃÊûµÇ¾î Melt Granulation & Pelletization, High Shear & Fluid Bed Processes, One Pot Technology, Technical Transfer and Scale Up Considerations for Solid Dosage, Continuous Tabletting, Tabletting of MUPS and ODT Products, Dissolution Testing of Pharmaceutical Solid Dosage Forms µîÀÇ ´Ù¾çÇÑ ÁÖÁ¦ÀÇ °Àǰ¡ Á¦°øµË´Ï´Ù.
½Ì°¡Æ÷¸£´ëÇб³ ¾à´ëÀÇ Paul Heng±³¼ö, Rutgers University ¾à´ë ±³¼ö¿´´ø Dr. Metin Celik, Pfizer Global R&DÀÇ Dr. Josephine Soh¿Í ÇÔ²² GEA ¹× Agilent¿¡¼ ÆÄ°ßµÈ ¿¬ÀÚµéÀÌ °¿¬À» ´ã´çÇÏ°Ô µË´Ï´Ù. |
|
|